Nu Skin Enterprises, Inc. (NUS): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$600.07M
As of 2025-12-31
$578.79M
As of 2026-06-30
-13.4%
3-year compound annual growth
-10.8%
5-year compound annual growth
-1.2%
10-year compound annual growth
$1.06B2009-12-31: $372.76M2010-12-31: $420.98M2011-12-31: $416.72M2012-12-31: $534.20M2013-12-31: $962.44M2014-12-31: $672.00M2015-12-31: $680.22M2016-12-31: $809.98M2017-12-31: $885.28M2018-12-31: $912.58M2019-12-31: $893.72M2020-12-31: $1.06B2021-12-31: $993.71M2022-12-31: $923.67M2023-12-31: $986.66M2024-12-31: $817.46M2025-12-31: $600.07M$600.07M
2009-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$600.07M-26.6%2026-02-13, Balance as of period end
2024-12-31$817.46M-17.1%2026-02-13, Balance as of period end
2023-12-31$986.66M+6.8%2025-02-14, Balance as of period end
2022-12-31$923.67M-7.0%2024-02-15, Balance as of period end
2021-12-31$993.71M-6.5%2023-02-16, Balance as of period end
2020-12-31$1.06B+18.9%2022-02-16, Balance as of period end
2019-12-31$893.72M-2.1%2021-02-11, Balance as of period end
2018-12-31$912.58M+3.1%2020-02-13, Balance as of period end
2017-12-31$885.28M+9.3%2019-02-14, Balance as of period end
2016-12-31$809.98M+19.1%2018-02-16, Balance as of period end
2015-12-31$680.22M+1.2%2017-02-27, Balance as of period end
2014-12-31$672.00M-30.2%2016-02-18, Balance as of period end
2013-12-31$962.44M+80.2%2015-03-02, Balance as of period end
2012-12-31$534.20Mn/c2014-03-18, Balance as of period end
2011-12-31$416.72M-1.0%2013-02-27, Balance as of period end
2010-12-31$420.98M+12.9%2012-02-28, Balance as of period end
2009-12-31$372.76Mn/a2011-02-23, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Nu Skin Enterprises, Inc. (NUS)2025-12-31$600.07M-26.6%
Herbalife Ltd. (HLF)2025-12-31$3.30B-6.6%
Cosmos Health Inc. (COSM)2025-12-31$47.05M+58.0%
DataMeds AI, Inc. (MEDS)2025-12-31$42.91M-15.2%
Stemtech Corp (STEK)2025-12-31$10.59M+21.1%

Compare NUS, HLF, COSM, MEDS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗